Zumutor is now headquartered in Woburn, MA with R & D Lab in Bangalore, has raised significant capital to pursue its goal of developing treatment-altering biologics.
Its focus on delivering biobetters, biological drugs of tomorrow, combined with significant opportunities for value creation has attracted the attention of several prominent venture capital houses.
Notable among them are:
a globally known firm that has supported some of the best names in business, such as Facebook, Flipkart, etc.
a VC giant that manages more than US$ 6 billion globally, with an India-focussed US$150 million technology venture capital fund
Aarin Capital Partners
which nurture enterprise from incubation till exit, and has a portfolio of companies in emerging business areas
the government-backed Karnataka Information Technology Venture Capital Fund, focussed on investments in Karnataka, India
Kavitha Iyer Rodrigues, CEO, says,
“With these associations, we look to leverage global expertise, M&A experience and support for operational excellence, which will position Zumutor as a key global biotech healthcare player. Our world-class team of antibody engineers works in convergence with eminent authorities in the field of immune-oncotherapeutics to enable a robust pipeline of new biological entities.”
Zumutor Biologics Inc. is a niche, innovation driven biologics company registered in the state of Delaware, with its office in Woburn, MA. Expertise and acumen of the Zumutor team is focused on development of new products through patent-pending technology platforms in our state of the art R&D facility in India
Zumutor also offers differentiated services ranging from co-development of monoclonal antibodies to recombinant technology based biosimilars